faculty photo

Sean Hennessy, PharmD, PhD

Professor of Epidemiology in Biostatistics and Epidemiology
Department: Biostatistics and Epidemiology

Contact information
University of Pennsylvania
423 Guardian Drive
803 Blockley Hall
Philadelphia, PA 19104-6021
Office: 215-898-9112
Fax: 215-573-5315
Education:
BS (Pharmacy)
Philadelphia College of Pharmacy and Science, 1989.
PharmD (Clinical Pharmacy)
Philadelphia College of Pharmacy and Science, 1990.
MSCE (Clinical Epidemiology)
University of Pennsylvania School of Medicine, 1996.
PhD (Epidemiology with Biostatistics minor)
University of Pennsylvania, 2002.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Chen C, Hennessy S, Brensinger CM, Miano TA, Bilker WB, Dublin S, Chung SP, Horn JR, Tiwari A, Leonard CE: Comparative risk of injury with concurrent use of opioids and skeletal muscle relaxants. Clinical Pharmacology and Therapeutics 2024 (https://doi.org/10.1002/cpt.3248).

Torgersen T, Mezochow AK,Newcomb CW, Carbonari DM, Hennessy S, CT Rentsch, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B,Roy JA, Taddei TH, Justice AC, Lo Re III V: Rates of severe acute liver injury after hepatotoxic medication initiation in real-world data. JAMA Internal Medicine 2024 (forthcoming).

Brumberg K, Ellis DE, Small DS, Hennessy S, Rosenbaum PR: Using natural strata when examining unmeasured biases in an observational study of neurological side effects of antibiotics. Journal of the Royal Statistical Society: Series C 2023 (https://doi.org/10.1093/jrsssc/qlad010).

Shah M, Mamtani R, Marmarelis ME, Hennessy S: Chemoimmunotherapy versus immunotherapy for first line treatment of advanced non-small cell lung 2 cancer with a PD-L1 expression >=50% or >=90%. Clinical Lung Cancer 2023 (https://doi.org/10.1016/j.cllc.2023.02.007).

Roy S, Ye T, Ertefaie A, Vo T-T, Flory J, Hennessy S, Small D: Group sequential testing under instrumented difference-in-differences approach. Statistics in Medicine 2023 (https://doi.org/10.1002/sim.9836).

Micale C, Golder S, O'Connor K, Weissenbacher D, Gross R, Hennessy S, Gonzalez-Hernandez G: Patient‑reported reasons for antihypertensive medication change: A quantitative study using social media. Drug Safety 2023 (doi: 10.1007/s40264-023-01366-5).

Pham Nguyen TP, Gray SL, Newcomb CW, Liu Q, Hamedani AG, Weintraub D, Hennessy S, Willis AW.: Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury. Parkinsonism & Related Disorders 2023 (doi.org/10.1016/j.parkreldis.2023.105793).

Abraham AS, Nguyen TPP, Newcomb CW, Gray SL, Hennessy S, Leonard CE, Liu Q, Weintraub D, Willis AW: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease. Parkinsonism and Related Disorders 2023 (DOI: 10.1016/j.parkreldis.2023.105822).

Dhopeshwarkar N, Yang W, Hennessy S, Rhodes JM, Cuker A, Leonard CE: Combining SuperLearner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemia. Pharmacoepidemiology and Drug Safety 2023 (DOI: 10.1002/pds.5678 ).

Golder S, Medaglio D, O'Connor K, Hennessy S, Gross R, Gonzalez Hernandez G: Reasons for discontinuation or change of selective serotonin reuptake inhibitors in online drug reviews. JAMA Network Open 6: e2323746, 2023.

back to top
Last updated: 04/15/2024
The Trustees of the University of Pennsylvania